001     276344
005     20250603100721.0
024 7 _ |a 10.1002/mrm.30368
|2 doi
024 7 _ |a pmid:39568225
|2 pmid
024 7 _ |a pmc:PMC11782714
|2 pmc
024 7 _ |a 1522-2594
|2 ISSN
024 7 _ |a 0740-3194
|2 ISSN
024 7 _ |a altmetric:171655164
|2 altmetric
037 _ _ |a DZNE-2025-00292
041 _ _ |a English
082 _ _ |a 610
100 1 _ |a Blömer, Simon
|0 P:(DE-2719)9001302
|b 0
|e First author
245 _ _ |a Proton-free induction decay MRSI at 7 T in the human brain using an egg-shaped modified rosette K-space trajectory.
260 _ _ |a New York, NY [u.a.]
|c 2025
|b Wiley-Liss
336 7 _ |a article
|2 DRIVER
336 7 _ |a Output Types/Journal article
|2 DataCite
336 7 _ |a Journal Article
|b journal
|m journal
|0 PUB:(DE-HGF)16
|s 1748936611_11720
|2 PUB:(DE-HGF)
336 7 _ |a ARTICLE
|2 BibTeX
336 7 _ |a JOURNAL_ARTICLE
|2 ORCID
336 7 _ |a Journal Article
|0 0
|2 EndNote
520 _ _ |a Proton (1H)-MRSI via spatial-spectral encoding poses high demands on gradient hardware at ultra-high fields and high-resolutions. Rosette trajectories help alleviate these problems, but at reduced SNR-efficiency because of their k-space densities not matching any desired k-space filter. We propose modified rosette trajectories, which more closely match a Hamming filter, and thereby improve SNR performance while still staying within gradient hardware limitations and without prolonging scan time.Analytical and synthetic simulations were validated with phantom and in vivo measurements at 7 T. The rosette and modified rosette trajectories were measured in five healthy volunteers in 6 min in a 2D slice in the brain. An elliptical phase-encoding sequence was measured in one volunteer in 22 min, and a 3D sequence was measured in one volunteer within 19 min. The SNR per-unit-time, linewidth, Cramer-Rao lower bounds (CRLBs), lipid contamination, and data quality of the proposed modified rosette trajectory were compared to the rosette trajectory.Using the modified rosette trajectories, an improved k-space weighting function was achieved resulting in an SNR per-unit-time increase of up to 12% compared to rosette's and 23% compared to elliptical phase-encoding, dependent on the two additional trajectory parameters. Similar results were achieved for the theoretical SNR calculation based on k-space densities, as well as when using the pseudo-replica method for simulated, in vivo, and phantom data. The CRLBs of γ-aminobutyric acid and N-acetylaspartylglutamate improved non-significantly for the modified rosette trajectory, whereas the linewidths and lipid contamination remained similar.By optimizing the shape of the rosette trajectory, the modified rosette trajectories achieved higher SNR per-unit-time and enhanced data quality at the same scan time.
536 _ _ |a 353 - Clinical and Health Care Research (POF4-353)
|0 G:(DE-HGF)POF4-353
|c POF4-353
|f POF IV
|x 0
588 _ _ |a Dataset connected to CrossRef, PubMed, , Journals: pub.dzne.de
650 _ 7 |a 7 T
|2 Other
650 _ 7 |a SNR efficiency
|2 Other
650 _ 7 |a gradient hardware restrictions
|2 Other
650 _ 7 |a magnetic resonance spectroscopic imaging
|2 Other
650 _ 7 |a modified rosette trajectory
|2 Other
650 _ 7 |a non‐Cartesian trajectory
|2 Other
650 _ 7 |a Protons
|2 NLM Chemicals
650 _ 2 |a Humans
|2 MeSH
650 _ 2 |a Phantoms, Imaging
|2 MeSH
650 _ 2 |a Brain: diagnostic imaging
|2 MeSH
650 _ 2 |a Algorithms
|2 MeSH
650 _ 2 |a Signal-To-Noise Ratio
|2 MeSH
650 _ 2 |a Adult
|2 MeSH
650 _ 2 |a Magnetic Resonance Imaging: methods
|2 MeSH
650 _ 2 |a Protons
|2 MeSH
650 _ 2 |a Computer Simulation
|2 MeSH
650 _ 2 |a Male
|2 MeSH
650 _ 2 |a Reproducibility of Results
|2 MeSH
650 _ 2 |a Female
|2 MeSH
650 _ 2 |a Image Processing, Computer-Assisted: methods
|2 MeSH
650 _ 2 |a Healthy Volunteers
|2 MeSH
700 1 _ |a Hingerl, Lukas
|b 1
700 1 _ |a Marjańska, Małgorzata
|0 0000-0002-4727-2447
|b 2
700 1 _ |a Bogner, Wolfgang
|b 3
700 1 _ |a Motyka, Stanislav
|0 0000-0002-6314-316X
|b 4
700 1 _ |a Hangel, Gilbert
|b 5
700 1 _ |a Klauser, Antoine
|b 6
700 1 _ |a Andronesi, Ovidiu C
|0 0000-0002-7412-0641
|b 7
700 1 _ |a Strasser, Bernhard
|b 8
773 _ _ |a 10.1002/mrm.30368
|g Vol. 93, no. 4, p. 1443 - 1457
|0 PERI:(DE-600)1493786-4
|n 4
|p 1443 - 1457
|t Magnetic resonance in medicine
|v 93
|y 2025
|x 1522-2594
856 4 _ |u https://pub.dzne.de/record/276344/files/DZNE-2025-00292%20SUP.doc
856 4 _ |u https://pub.dzne.de/record/276344/files/DZNE-2025-00292%20SUP.docx
856 4 _ |u https://pub.dzne.de/record/276344/files/DZNE-2025-00292%20SUP.odt
856 4 _ |u https://pub.dzne.de/record/276344/files/DZNE-2025-00292%20SUP.pdf
856 4 _ |u https://pub.dzne.de/record/276344/files/DZNE-2025-00292.pdf
|y OpenAccess
856 4 _ |u https://pub.dzne.de/record/276344/files/DZNE-2025-00292.pdf?subformat=pdfa
|x pdfa
|y OpenAccess
909 C O |o oai:pub.dzne.de:276344
|p openaire
|p open_access
|p VDB
|p driver
|p dnbdelivery
910 1 _ |a Deutsches Zentrum für Neurodegenerative Erkrankungen
|0 I:(DE-588)1065079516
|k DZNE
|b 0
|6 P:(DE-2719)9001302
913 1 _ |a DE-HGF
|b Gesundheit
|l Neurodegenerative Diseases
|1 G:(DE-HGF)POF4-350
|0 G:(DE-HGF)POF4-353
|3 G:(DE-HGF)POF4
|2 G:(DE-HGF)POF4-300
|4 G:(DE-HGF)POF
|v Clinical and Health Care Research
|x 0
914 1 _ |y 2025
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0200
|2 StatID
|b SCOPUS
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0160
|2 StatID
|b Essential Science Indicators
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1050
|2 StatID
|b BIOSIS Previews
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1190
|2 StatID
|b Biological Abstracts
|d 2025-01-02
915 _ _ |a Creative Commons Attribution CC BY 4.0
|0 LIC:(DE-HGF)CCBY4
|2 HGFVOC
915 _ _ |a DEAL Wiley
|0 StatID:(DE-HGF)3001
|2 StatID
|d 2025-01-02
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1030
|2 StatID
|b Current Contents - Life Sciences
|d 2025-01-02
915 _ _ |a WoS
|0 StatID:(DE-HGF)0113
|2 StatID
|b Science Citation Index Expanded
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0150
|2 StatID
|b Web of Science Core Collection
|d 2025-01-02
915 _ _ |a OpenAccess
|0 StatID:(DE-HGF)0510
|2 StatID
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0300
|2 StatID
|b Medline
|d 2025-01-02
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)1110
|2 StatID
|b Current Contents - Clinical Medicine
|d 2025-01-02
915 _ _ |a Nationallizenz
|0 StatID:(DE-HGF)0420
|2 StatID
|d 2025-01-02
|w ger
915 _ _ |a DBCoverage
|0 StatID:(DE-HGF)0199
|2 StatID
|b Clarivate Analytics Master Journal List
|d 2025-01-02
920 1 _ |0 I:(DE-2719)1011101
|k Patient Studies (Bonn)
|l Patient Studies (Bonn)
|x 0
980 _ _ |a journal
980 _ _ |a VDB
980 _ _ |a I:(DE-2719)1011101
980 _ _ |a UNRESTRICTED
980 1 _ |a FullTexts


LibraryCollectionCLSMajorCLSMinorLanguageAuthor
Marc 21